Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status:
Recruiting
Trial end date:
2022-11-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of perampanel during the
Maintenance Period of the Core Study following oral suspension administration given as an
adjunctive therapy in pediatric participants from 1 month to less than 4 years of age with
epilepsy.